• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

131.65 +0.81 (+0.62%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,517,174
Open 130.00
Bid (Size) 131.40 (900)
Ask (Size) 133.10 (200)
Prev. Close 130.84
Today's Range 129.01 - 132.36
52wk Range 95.30 - 157.29
Shares Outstanding 1,253,809,440
Dividend Yield 2.40%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences
Today 6:00 EDT
From Gilead Sciences, Inc.
Via Business Wire
News headline image
2 Nasdaq 100 Stocks with Solid Fundamentals and 1 We Find Risky
Today 0:31 EDT
The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a win... 
Via StockStory

Performance

YTD
+8.3%
+8.3%
1 Month
-6.2%
-6.2%
3 Month
-7.3%
-7.3%
6 Month
+9.9%
+9.9%
1 Year
+27.5%
+27.5%

More News

Read More
News headline image
Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish?
April 30, 2026
Via Barchart.com
Topics ETFs
News headline image
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today ↗
April 29, 2026
Via Benzinga
Gilead Sciences Inc (NASDAQ:GILD): A Balanced Dividend Play with Strong Financial Health and Profitability ↗
April 25, 2026
Via Chartmill
Gilead Sciences (NASDAQ:GILD): A Value Screen Candidate with Strong Profitability ↗
April 20, 2026
Via Chartmill
News headline image
Opes Wealth Sells Its Entire FIXD Stake -- Is This $9.3 Million Bond ETF Exit A Signal? ↗
April 29, 2026
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir
April 29, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
April 28, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
3 Healthcare Stocks That Pay You While You Wait for the Growth ↗
April 27, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down
April 24, 2026
Via StockStory
News headline image
Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
April 22, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
What's Going On With Arcus Biosciences Stock On Wednesday? ↗
April 22, 2026
Via Benzinga
News headline image
Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others ↗
April 20, 2026
Via Investor's Business Daily
News headline image
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗
April 14, 2026
Via Benzinga
News headline image
PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access
April 14, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
April 14, 2026
Via StockStory
News headline image
Q4 Earnings Highs And Lows: Gilead Sciences (NASDAQ:GILD) Vs The Rest Of The Therapeutics Stocks
April 12, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Gilead Expands Partnership With Tempus AI To Power Cancer Discoveries ↗
April 10, 2026
Via Benzinga
Topics Artificial Intelligence
News headline image
Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis
April 09, 2026
Via MarketMinute
Topics Bonds
News headline image
Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline ↗
April 09, 2026
Via Benzinga
Topics Artificial Intelligence
News headline image
Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal ↗
April 07, 2026
Via Benzinga
News headline image
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
April 07, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Gilead Extends Tender Offer for Arcellx as Biotech M&A Sentiment Faces a Reality Check
April 06, 2026
Via MarketMinute
News headline image
Gilead Extends Tender Offer to Acquire Arcellx
April 01, 2026
From Gilead Sciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 131.65
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 05/01/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 165.06B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 165B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap